A feasibility study of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and IP paclitaxel in patients with epithelial ovarian carcinoma, fallopian tube carcinoma, or peritoneal carcinoma

被引：0
作者：
Nagao, S. [1 ]
Oishi, R. [1 ]
Iwasa, N. [1 ]
Shimizu, M. [1 ]
Hasegawa, K. [1 ]
Goto, T. [1 ]
Fujiwara, K. [1 ]
机构：
[1] Saitama Med Univ Int, Med Ctr, Hidaka City, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16549
引用
收藏
页数：2
相关论文
共 50 条
[21]   Comparison of toxicities between intraperitoneal (IP) versus intravenous (IV) administration of carboplatin in combination with IV paclitaxel. [J].
Fujiwara, K ;
Ishikawa, H ;
Kigawa, J ;
Akamatsu, N ;
Noma, J ;
Miyagi, Y ;
Okada, M ;
Murakami, T ;
Nagao, S ;
Kohno, I .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :465S-465S
[22]   A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. [J].
Bell-McGuinn, Katherine M. y ;
Brady, William E. ;
Schilder, Russell J. ;
Fracasso, Paula M. ;
Moore, Kathleen N. ;
Walker, Joan L. ;
Duska, Linda R. ;
Mathews, Cara Amanda ;
Chen, Alice ;
Shepherd, Stacie Peacock ;
Giranda, Vincent L. ;
Aghajanian, Carol .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[23]   Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer [J].
Micha, JP ;
Goldstein, BH ;
Rettenmaier, MA ;
Mattison, J ;
Graham, C ;
Birk, CL ;
Brown, JV .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :719-724
[24]   Multi-institutional retrospective study of 64 patients with primary fallopian tube carcinoma treated with carboplatin and paclitaxel [J].
Papaxoinis, G. ;
Andreadis, C. ;
Fountzilas, G. ;
Aravantinos, G. ;
Sykiotis, C. ;
Akrivos, T. ;
Pectasides, D. .
EJC SUPPLEMENTS, 2009, 7 (02) :469-469
[25]   MANAGEMENT OF PERITONEAL METASTASES IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA [J].
Gao, Yunong .
ANTICANCER RESEARCH, 2015, 35 (07) :4301-4302
[26]   A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus [J].
Pothuri, B. ;
Sawaged, Z. ;
Karpel, H. C. ;
Li, X. ;
Lee, J. ;
Musa, F. ;
Lutz, K. ;
Reese, E. ;
Blank, S. V. ;
Boyd, L. R. ;
Curtin, J. P. ;
Goldberg, J. D. ;
Muggia, F. M. .
GYNECOLOGIC ONCOLOGY, 2024, 190 :209-214
[27]   Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III-IV Ovarian Serous Carcinoma [J].
Kawaguchi, R. ;
Tanase, Y. ;
Haruta, S. ;
Nagai, A. ;
Yoshida, S. ;
Furukawa, N. ;
Ooi, H. ;
Kobayashi, K. .
CASE REPORTS IN ONCOLOGY, 2012, 5 (01) :173-180
[28]   Quality of life (QOL) results of a randomized study of intravenous (IV) paclitaxel and cisplatin vs IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): A Gynecologic Oncology Group trial. [J].
Wenzel, LB ;
Huang, H ;
Armstrong, D ;
Walker, J ;
Cella, D .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :455S-455S
[29]   Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancer [J].
Taylor, Sarah E. ;
Li, Ruosha ;
Petschauer, Jennifer S. ;
Donovan, Heidi ;
O'Neal, Sara ;
Keeler, Amanda W. ;
Zamboni, William C. ;
Edwards, Robert P. ;
Zorn, Kristin K. .
GYNECOLOGIC ONCOLOGY, 2015, 138 (03) :548-553
[30]   A phase II study of modified dose-dense paclitaxel and every 4 week carboplatin for the treatment of advanced stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma [J].
Abaid, L. ;
Micha, J. ;
Rettenmaier, M. ;
Brown, J. ;
Mendivil, A. ;
Lopez, K. ;
Goldstein, B. .
GYNECOLOGIC ONCOLOGY, 2012, 125 :S112-S112
12345